4//SEC Filing
Carter Martha J. 4
Accession 0001209191-22-004067
CIK 0001322505other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:54 PM ET
Size
7.8 KB
Accession
0001209191-22-004067
Insider Transaction Report
Form 4
Carter Martha J.
Chief Regulatory Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-18+15,900→ 15,900 totalExercise: $26.75Exp: 2032-01-17→ Common Stock (15,900 underlying) - Award
Common Stock
2022-01-18+10,800→ 16,300 total
Footnotes (3)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.
- [F2]Represents 16,300 restricted stock units.
- [F3]This option vests as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeother
Related Parties
1- filerCIK 0001213040
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:54 PM ET
- Size
- 7.8 KB